• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 - Product Image

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

  • Published: January 2012
  • Region: Global
  • 104 pages
  • GlobalData

FEATURED COMPANIES

  • Eli Lilly and Company
  • Medtronic Inc.
  • Novo Nordisk A/S
  • Sanofi
  • MORE

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global insulin delivery devices market. The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.
- Annualized market READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Disease Overview - Diabetes
3.1 Types of Diabetes
3.1.1 Type 1 Diabetes
3.1.2 Type 2 Diabetes
3.1.3 Gestational Diabetes
3.2 Signs and Symptoms
3.3 Diagnosis
3.3.1 Fasting Plasma Glucose Test
3.3.2 Oral Glucose Tolerance Test
3.3.3 Random Plasma Glucose Test
3.4 Epidemiology
3.4.1 Epidemiology of Diabetes in the US
3.4.2 Epidemiology of Diabetes in the UK
3.4.3 Epidemiology of Diabetes in Japan
3.4.4 Epidemiology of Diabetes in India
3.4.5 Epidemiology of Diabetes in China
4 Insulin Delivery Devices - Overview
4.1 Insulin Delivery Devices, Market Segmentation
4.1.1 Insulin Pen
4.1.2 Insulin Pump
4.1.3 Insulin Syringe
4.1.4 Traditional Insulin Pump Accessories
4.2 Comparison of Insulin Delivery Devices
5 Insulin Delivery Devices - Global Market Characterization
5.1 Insulin Delivery Devices Market, Global, Revenue ($bn), Historic, 2003-2010
5.2 Insulin Delivery Devices Market, Global, Revenue ($bn), Forecast, 2010-2017
5.3 Global Insulin Delivery Devices Market, Key Trends
5.3.1 More People Use Insulin Pumps in the US than in European Countries, where Insulin Pens are the Preferred Choice
5.3.2 Disposable Insulin Pumps to Gain Market Share at the Expense of Traditional Insulin Pumps
5.3.3 Partnerships between Insulin Manufacturers and Insulin Delivery Devices Companies is a Recent Trend in the Insulin Delivery Devices Market
5.3.4 Food and Drug Administration to Tighten the Regulation of Infusion Pumps
5.3.5 Co-Marketing of Insulin Pumps with Blood Glucose Monitoring/Continuous Glucose Monitor Devices is a Recent Market Trend
5.3.6 Artificial Pancreas to be a Future Trend in the Insulin Pumps Market
5.4 Global Insulin Delivery Devices, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
6 Global Insulin Delivery Devices Market - Analysis by Segment
6.1 Insulin Pens, Global, Revenue ($m), Historic, 2003-2010
6.2 Insulin Pens, Global, Revenue ($m), Forecast, 2010-2017
6.2.1 Market Drivers
6.2.2 Market Restraints
6.3 Insulin Pumps, Global, Revenue ($m), Historic, 2003-2010
6.4 Insulin Pumps, Global, Revenue ($m), Forecast, 2010-2017
6.4.1 Market Drivers
6.4.2 Market Restraints
6.5 Insulin Syringes, Global, Revenue ($m), Historic, 2003-2010
6.6 Insulin Syringes, Global, Revenue ($m), Forecast, 2010-2017
6.6.1 Market Drivers
6.6.2 Market Restraints
6.7 Traditional Insulin Pump Accessories, Global, Revenue ($bn), History, 2003-2010
6.8 Traditional Insulin Pump Accessories, Global, Revenue ($bn), Forecast, 2010-2017
7 Insulin Delivery Devices Market - Analysis and Forecasts by Country, Revenue ($m), 2003-2017
7.1 Insulin Delivery Devices Market, The US, Revenue ($m), Historic, 2003-2010
7.2 Insulin Delivery Devices Market, The US, Revenue ($m), Forecast, 2010-2017
7.3 Insulin Delivery Devices Market, Canada, Revenue ($m), Historic, 2003-2010
7.4 Insulin Delivery Devices Market, Canada, Revenue ($m), Forecast, 2010-2017
7.5 Insulin Delivery Devices Market, The UK, Revenue ($m), Historic, 2003-2010
7.6 Insulin Delivery Devices Market, The UK, Revenue ($m), Forecast, 2010-2017
7.7 Insulin Delivery Devices Market, Germany, Revenue ($m), Historic, 2003-2010
7.8 Insulin Delivery Devices Market, Germany, Revenue ($m), Forecast, 2010-2017
7.9 Insulin Delivery Devices Market, France, Revenue ($m), Historic, 2003-2010
7.10 Insulin Delivery Devices Market, France, Revenue ($m), Forecast, 2010-2017
7.11 Insulin Delivery Devices Market, Italy, Revenue ($m), Historic, 2003-2010
7.12 Insulin Delivery Devices Market, Italy, Revenue ($m), Forecast, 2010-2017
7.13 Insulin Delivery Devices Market, Spain, Revenue ($m), Historic, 2003-2010
7.14 Insulin Delivery Devices Market, Spain, Revenue ($m), Forecast, 2010–2017
7.15 Insulin Delivery Devices Market, Japan, Revenue ($m), Historic, 2003-2010
7.16 Insulin Delivery Devices Market, Japan, Revenue ($m), Forecast, 2010-2017
7.17 Insulin Delivery Devices Market, China, Revenue ($m), Historic, 2003-2010
7.18 Insulin Delivery Devices Market, China, Revenue ($m), Forecast, 2010-2017
7.19 Insulin Delivery Devices Market, India, Revenue ($’000), Historic, 2003-2010
7.20 Insulin Delivery Devices Market, India, Revenue ($’000), Forecast, 2010-2017
7.21 Insulin Delivery Devices Market, Australia, Revenue ($m), Historic, 2003-2010
7.22 Insulin Delivery Devices Market, Australia, Revenue ($m), Forecast, 2010-2017
7.23 Insulin Delivery Devices Market, Brazil, Revenue ($m), Historic, 2003-2010
7.24 Insulin Delivery Devices Market, Brazil, Revenue ($m), Forecast, 2010-2017
8 Global Insulin Delivery Devices Market - Competitive Assessment
8.1 Insulin Delivery Devices Market, Global, Key Company Share (%), 2010
8.2 Insulin Delivery Devices, Global, Key Market Participants
8.2.1 Medtronic Inc.
8.2.2 Novo Nordisk A/S
8.2.3 Sanofi
8.2.4 Eli Lilly and Company
8.2.5 Becton, Dickinson and Company
8.2.6 F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG)
9 Insulin Delivery Devices - Pipeline Assessment
9.1 Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011
9.2 Pipeline Assessment by Developmental Stage and Territory, 2011
9.2.1 Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011
9.2.2 Key Pipeline Products, Insulin Pumps
9.2.3 Insulin Pens, Pipeline by Developmental Stage and Territory, 2011
9.2.4 Key Pipeline Products, Insulin Pens
9.2.5 Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011
9.2.6 Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011
9.2.7 Key Pipeline Products, Other Insulin Delivery Devices
10 Global Insulin Delivery Devices Market - Strategic Deals Analysis
10.1 Key Deals, Insulin Delivery Devices Market
10.1.1 Haselmeier Enters into Distribution Agreement with Biocon
10.1.2 Cellnovo Enters into Technology Integration Agreement with LifeScan
10.1.3 Insulet Announces Acquisition of Neighborhood Diabetes
10.1.4 Insulet Enters into Distribution Agreement with GlaxoSmithKline
10.1.5 Cellnovo Enters into Agreement with Home Diagnostics
10.1.6 Roche Holding Acquires Medingo from Elron Electronic Industries
10.1.7 JDRF Enters into Agreement with Becton, Dickinson and Company
10.1.8 Insulet Enters into Distribution Agreement with Ypsomed Holding
11 Appendix
11.1 Market Definitions
11.1.1 Insulin Delivery Devices
11.2 Abbreviations
11.3 Research Methodology
11.3.1 Secondary Research
11.3.2 Primary Research
11.3.3 Models
11.3.4 Forecasts
11.3.5 Expert Panel
11.4 GlobalData Consulting
11.5 Contact Us
11.6 Disclaimer
11.7 Sources

1.1 List of Tables
Table 1: Fasting Plasma Glucose Test
Table 2: Oral Glucose Tolerance Test
Table 3: Oral Glucose Tolerance Test for Gestational Diabetes
Table 4: Diabetes Prevalence (%) and Patient Population, by Country, 2011
Table 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010
Table 6: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017
Table 7: Insulin Pumps Market, Global, 2006-2010
Table 8: Organizations/Companies Developing Artificial Pancreas
Table 9: Annual Increase in the Incidence of Diabetes Among Children in Europe, 1983-2005
Table 10: Studies Indicating Safety and Efficacy of Insulin Pumps
Table 11: Studies Suggesting Higher Risk of Ketoacidosis from Insulin Pump Use, 2004 and 2009
Table 12: Insulin Pens, Global, Revenue ($m), 2003-2010
Table 13: Insulin Pens, Global, Revenue ($m), 2010-2017
Table 14: Studies Suggesting Advantages of Insulin Pens Over Insulin Syringes, 2008-2011
Table 15: Studies Suggesting Better Patient Compliance with Insulin Pens than Insulin Syringes, 2007-2010
Table 16: Insulin Pumps, Global, Revenue ($m), 2003-2010
Table 17: Insulin Pumps, Global, Revenue ($m), 2010-2017
Table 18: Studies Indicating Safety and Efficacy of Insulin Pump Therapy in Pregnant Women, 2001-2011
Table 19: Insulin Syringes, Global, Revenue ($m), 2003-2010
Table 20: Insulin Syringes, Global, Revenue ($m), 2010-2017
Table 21: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010
Table 22: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017
Table 23: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010
Table 24: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017
Table 25: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010
Table 26: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017
Table 27: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011
Table 28: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011
Table 29: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011
Table 30: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010
Table 31: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017
Table 32: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010
Table 33: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017
Table 34: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010
Table 35: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017
Table 36: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010
Table 37: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017
Table 38: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010
Table 39: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010-2017
Table 40: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010
Table 41: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017
Table 42: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010
Table 43: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017
Table 44: Insulin Delivery Devices Market, India, Revenue ($’000), 2003-2010
Table 45: Insulin Delivery Devices Market, India, Revenue ($’000), 2010-2017
Table 46: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010
Table 47: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017
Table 48: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010
Table 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017
Table 50: Insulin Delivery Devices Market, Global, Key Company Revenue ($m), 2010
Table 51: Pipeline Products, Medtronic Inc.
Table 52: Key Insulin Delivery Products, Medtronic Inc.
Table 53: Key Insulin Delivery Products, Novo Nordisk A/S
Table 54: Key Insulin Delivery Products, Sanofi
Table 55: Key Insulin Delivery Products, Eli Lilly and Company
Table 56: Insulin Delivery Devices, Becton, Dickinson and Company
Table 57: Key Insulin Delivery Products, Becton, Dickinson and Company
Table 58: Key Insulin Delivery Products, Disetronic Medical Systems AG
Table 59: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011
Table 60: Insulin Pumps, Pipeline by Developmental Stage and Territory, 2011
Table 61: Artificial Pancreas System (Boston University), Clinical Trial Details
Table 62: Artificial Pancreas System (University of Virginia), Clinical Trial Details
Table 63: Paradigm Veo System, Clinical Trial Details
Table 64: Insulin Pens, Pipeline by Developmental Stage and Territory, 2011
Table 65: NovoPen Echo, Clinical Trial Details
Table 66: Insulin Syringes, Pipeline by Developmental Stage and Territory, 2011
Table 67: Other Insulin Delivery Devices, Pipeline by Developmental Stage and Territory, 2011
Table 68: AFREZZA - Medtone Inhaler, Clinical Trial Details
Table 69: Key Deals, Insulin Delivery Devices Market, 2009-2011

1.2 List of Figures
Figure 1: Diabetes Prevalence (%), Global, 2011
Figure 2: Insulin Delivery Devices, Market Segmentation
Figure 3: Comparison of Insulin Delivery Devices
Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2003-2010
Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017
Figure 6: Insulin Pumps Market, Global, 2006-2010
Figure 7: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies
Figure 8: Partnerships between Insulin Manufacturers and Insulin Delivery Device Companies
Figure 9: Global Insulin Delivery Devices, Market Dynamics
Figure 10: Causes of Type 1 Diabetes in Children
Figure 11: Insulin Pens, Global, Revenue ($m), 2003-2010
Figure 12: Insulin Pens, Global, Revenue ($m), 2010-2017
Figure 13: Patient Perception Analysis for Insulin Pens and Insulin Syringes
Figure 14: Insulin Pumps, Global, Revenue ($m), 2003-2010
Figure 15: Insulin Pumps, Global, Revenue ($m), 2010-2017
Figure 16: Insulin Syringes, Global, Revenue ($m), 2003-2010
Figure 17: Insulin Syringes, Global, Revenue ($m), 2010-2017
Figure 18: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2003-2010
Figure 19: Traditional Insulin Pump Accessories, Global, Revenue ($bn), 2010-2017
Figure 20: Insulin Delivery Devices Market, The US, Revenue ($m), 2003-2010
Figure 21: Insulin Delivery Devices Market, The US, Revenue ($m), 2010-2017
Figure 22: Insulin Delivery Devices Market, Canada, Revenue ($m), 2003-2010
Figure 23: Insulin Delivery Devices Market, Canada, Revenue ($m), 2010-2017
Figure 24: Individual Out-of-Pocket Expenses for Diabetes Management in Canadian Provinces with Annual Income of <$15,000, June 2011
Figure 25: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $43,000, June 2011
Figure 26: Individual Out-of-Pocket Expenses for Type 1 Diabetes Management in Canadian Provinces with Annual Income of $75,000, June 2011
Figure 27: Insulin Delivery Devices Market, The UK, Revenue ($m), 2003-2010
Figure 28: Insulin Delivery Devices Market, The UK, Revenue ($m), 2010-2017
Figure 29: Insulin Delivery Devices Market, Germany, Revenue ($m), 2003-2010
Figure 30: Insulin Delivery Devices Market, Germany, Revenue ($m), 2010-2017
Figure 31: Insulin Delivery Devices Market, France, Revenue ($m), 2003-2010
Figure 32: Insulin Delivery Devices Market, France, Revenue ($m), 2010-2017
Figure 33: Insulin Delivery Devices Market, Italy, Revenue ($m), 2003-2010
Figure 34: Insulin Delivery Devices Market, Italy, Revenue ($m), 2010-2017
Figure 35: Insulin Delivery Devices Market, Spain, Revenue ($m), 2003-2010
Figure 36: Insulin Delivery Devices Market, Spain, Revenue ($m), 2010–2017
Figure 37: Insulin Delivery Devices Market, Japan, Revenue ($m), 2003-2010
Figure 38: Insulin Delivery Devices Market, Japan, Revenue ($m), 2010-2017
Figure 39: Insulin Delivery Devices Market, China, Revenue ($m), 2003-2010
Figure 40: Insulin Delivery Devices Market, China, Revenue ($m), 2010-2017
Figure 41: Insulin Delivery Devices Market, India, Revenue ($’000), 2003-2010
Figure 42: Insulin Delivery Devices Market, India, Revenue ($’000), 2010-2017
Figure 43: Insulin Delivery Devices Market, Australia, Revenue ($m), 2003-2010
Figure 44: Insulin Delivery Devices Market, Australia, Revenue ($m), 2010-2017
Figure 45: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2003-2010
Figure 46: Insulin Delivery Devices Market, Brazil, Revenue ($m), 2010-2017
Figure 47: Insulin Delivery Devices Market, Global, Key Company Share (%), 2010
Figure 48: Insulin Delivery Devices Market, Competitive Assessment
Figure 49: Insulin Delivery Devices, Pipeline Products by Stage of Development, 2011
Figure 50: Insulin Pumps, Pipeline Assessment by Developmental Stage, 2011

GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global insulin delivery devices market. The report provides market landscape, competitive landscape and market trends information on the insulin delivery devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The Global Insulin Delivery Devices Market is Forecast to Reach $11.1 Billion by 2017

Insulin Delivery Devices Market, Global, Revenue ($bn), 2010-2017

Sources: GlobalData, Annual Reports, SEC Filings, Investor Presentations, Earning Call Transcripts, News and Press Releases, Scientific Journals, Trade Associations, Interviews with Industry Experts and Key Opinion Leaders (KOLs)

The global insulin delivery devices market was valued at $7.4 billion in 2010 and is forecast to grow at a Compound Annual Growth Rate (CAGR) of 6% to exceed $11 billion in 2017. The market is expected to be driven by the significant increase in the prevalence of diabetes, particularly among children; the availability of reimbursement for insulin delivery devices; positive clinical outcomes from studies about the use of insulin pumps and their associated advantages for niche patient groups.

The US Remains the Largest Insulin Delivery Devices Market Driven by the High Penetration of Insulin Pumps and the Availability of Reimbursement

The US insulin delivery devices market was valued at $2.8 billion in 2010 and is expected to grow at a CAGR of 6% to reach $4.2 billion by 2017. The growth will be fuelled by a number of factors, such as the increase in the incidence of diabetes among all ages, higher market penetration of insulin pumps and the availability of reimbursement.

Insulin pumps are used more commonly in the US than in European countries. According to an article published in the Journal of Diabetes Science and Technology in May 2010, entitled “Evolution of Diabetes Insulin Delivery Devices”, insulin pumps are used more in the US for insulin delivery, whereas in Europe, insulin pens are more commonly used. According to Juvenile Diabetes Research Federation (JDRF) estimates, about 400,000 people in the US with type 1 diabetes use insulin pumps.

Medtronic Inc.
Novo Nordisk A/S
Sanofi
Eli Lilly and Company
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd. (Disetronic Medical Systems AG)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos